Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells

Toxicology and Applied Pharmacology

Volumn 255, Issue 1, 2011, Pages 94-102

  Ryu, Chang Seon ^a   Kwak, Hui Chan ^a   Lee, Kye Sook ^a   Kang, Keon Wook ^b   Oh, Soo Jin ^c   Lee, Ki Ho ^c   Kim, Hwan Mook ^c   Ma, Jin Yeul ^d   Kim, Sang Kyum ^a  

^a Chungnam National University   (South Korea)

^b Chosun University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Breast cancer; Doxorubicin resistance; Glutathione; Sulfur amino acid metabolism; Transsulfuration

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BLEOMYCIN; DOXORUBICIN; DRUG METABOLIZING ENZYME; GLUTATHIONE; HOMOCYSTEINE; MENADIONE; METHIONINE SYNTHASE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SULFUR AMINO ACID;

AMINO ACID METABOLISM; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL LEVEL; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; METHYLATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

AMINO ACIDS, SULFUR; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYSTEINE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUTATHIONE; HUMANS; METHIONINE; P-GLYCOPROTEIN; VITAMIN K 3;

EID: 79960840508     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.004     Document Type: Article

References (41)

1. Agostinelli E., Marques M.P., Calheiros R., Gil F.P., Tempera G., Viceconte N., Battaglia V., Grancara S., Toninello A. Polyamines: fundamental characters in chemistry and biology. Amino Acids 2010, 38:393-403.
2. Bagley P.J., Hirschberger L.L., Stipanuk M.H. Evaluation and modification of an assay procedure for cysteine dioxygenase activity: high-performance liquid chromatography method for measurement of cysteine sulfinate and demonstration of physiological relevance of cysteine dioxygenase activity in cysteine catabolism. Anal. Biochem. 1995, 227:40-48.
3. Batist G., Schecter R., Woo A., Greene D., Lehnert S. Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines. Biochem. Pharmacol. 1991, 41:631-635.
4. Bella D.L., Kwon Y.H., Hirschberger L.L., Stipanuk M.H. Post-transcriptional regulation of cysteine dioxygenase in rat liver. Adv. Exp. Med. Biol. 2000, 483:71-85.
5. Cellarier E., Durando X., Vasson M.P., Farges M.C., Demiden A., Maurizis J.C., Madelmont J.C., Chollet P. Methionine dependency and cancer treatment. Cancer Treat. Rev. 2003, 29:489-499.
6. Comporti M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 1989, 72:1-56.
7. Desai T.K., Maliakkal J., Kinzie J.L., Ehrinpreis M.N., Luk G.D., Cejka J. Taurine deficiency after intensive chemotherapy and/or radiation. Am. J. Clin. Nutr. 1992, 55:708-711.
8. Fairchild C.R., Ivy S.P., Kao-Shan C.S., Whang-Peng J., Rosen N., Israel M.A., Melera P.W., Cowan K.H., Goldsmith M.E. Isolation of amplified and overexpressed DNA sequences from adriamycin resistant human breast cancer cells. Cancer Res. 1987, 47:5141-5148.
9. Fairchild C.R., Moscow J.A., O'Brien E.E., Cowan K.H. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Mol. Pharmacol. 1990, 37:801-809.
10. Fan M., Yan P.S., Hartman-Frey C., Chen L., Paik H., Oyer S.L., Salisbury J.D., Cheng A.S., Li L., Abbosh P.H., Huang T.H., Nephew K.P. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res. 2006, 66:11954-11966.
11. Finkelstein J.D. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin. Chem. Lab. Med. 2007, 45:1694-1699.
12. Gamcsik M.P., Dubay G.R., Cox B.R. Increased rate of glutathione synthesis from cystine in drug-resistant MCF-7 cells. Biochem. Pharmacol. 2002, 63:843-851.
13. Garras A., Djurhuus R., Christensen B., Lillehaug J.R., Ueland P.M. A nonradioactive assay for N5-methyltetrahydrofolate-homocysteine methyltransferase (methionine synthase) based on o-phthaldialdehyde derivatization of methionine and fluorescence detection. Anal. Biochem. 1991, 199:112-118.
14. Gaudiano G., Koch T.H., Lo Bello M., Nuccetelli M., Ravagnan G., Serafino A., Sinibaldi-Vallebona P. Lack of glutathione conjugation to Adriamycin in human breast cancer MCF-7/DOX cells. Biochem. Pharmacol. 2000, 60:1915-1923.
15. Han C.Y., Cho K.B., Choi H.S., Han H.K., Kang K.W. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 2008, 29:1837-1844.
16. Huxtable R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 1989, 32:471-533.
17. Ide T. Simple high-performance liquid chromatographic method for assaying cysteinesulfinic acid decarboxylase activity in rat tissue. J. Chromatogr. B. Biomed. SciAppl. 1997, 694:325-332.
18. Jani T.S., Gobejishvili L., Hote P.T., Barve A.S., Joshi-Barve S., Kharebava G., Suttles J., Chen T., McClain C.J., Barve S. Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Res. 2009, 19:358-369.
19. Judde J.G., Ellis M., Frost P. Biochemical analysis of the role of transmethylation in the methionine dependence of tumor cells. Cancer Res. 1989, 49:4859-4865.
20. Kashiwamata S., Greenberg D.M. Studies on cystathionine synthase of rat liver. Properties of the highly purified enzyme. Biochim. Biophys. Acta 1970, 212:488-500.
21. Kim S.K., Kim Y.C. Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in mice. J. Hepatol. 2005, 42:907-913.
22. Kim S.K., Choi K.H., Kim Y.C. Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice. Biochem. Pharmacol. 2003, 65:1565-1574.
23. Kim S.K., Seo J.M., Jung Y.S., Kwak H.E., Kim Y.C. Alterations in hepatic metabolism of sulfur-containing amino acids induced by ethanol in rats. Amino Acids 2003, 24:103-110.
24. Lee K.H., Cava M., Amiri P., Ottoboni T., Lindquist R.N. Betaine:homocysteine methyltransferase from rat liver: purification and inhibition by a boronic acid substrate analog. Arch. Biochem. Biophys. 1992, 292:77-86.
25. Lombardini J.B., Sufrin J.R. Chemotherapeutic potential of methionine analogue inhibitors of tumor-derived methionine adenosyltransferases. Biochem. Pharmacol. 1983, 32:489-495.
26. Lu S.C. Regulation of glutathione synthesis. Mol. Aspects Med. 2009, 30:42-59.
27. Mato J.M., Martínez-Chantar M.L., Lu S.C. Methionine metabolism and liver disease. Annu. Rev. Nutr. 2008, 28:273-293.
28. Millis K.K., Lesko S.A., Gamcsik M.P. Formation, intracellular distribution and efflux of glutathione-bimane conjugates in drug-sensitive and -resistant MCF-7 cells. Cancer Chemother. Pharmacol. 1997, 40:101-111.
29. Nakaike S., Kashiwagi K., Terao K., Iio K., Igarashi K. Combined use of alpha difluoromethylornithine and an inhibitor of S-adenosylmethionine decarboxylase in mice bearing P388 leukemia or Lewis lung carcinoma. Jpn J. Cancer Res. 1988, 79:501-508.
30. Neuhäuser-Berthold M., Kuhfus A., Bässler K.H. Utilization of glutathione disulfide as cysteine source during long-term parenteral nutrition in the growing rat. Metabolism 1988, 37:796-801.
31. Nieminen M.L., Tuomisto L., Solatunturi E., Eriksson L., Paasonen M.K. Taurine in the osmoregulation of the Brattleboro rat. Life Sci. 1988, 42:2137-2143.
32. Nolin T.D., McMenamin M.E., Himmelfarb J. Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2007, 852:554-561.
33. Pasantes-Morales H., Wright D.E., Gaull G.E. Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem. Pharmacol. 1985, 34:2205-2207.
34. Poli P., Buschini A., Candi A., Rossi C. Bleomycin genotoxicity alteration by glutathione and cytochrome P-450 cellular content in respiratory proficient and deficient strains of Saccharomyces cerevisiae. Mutagenesis 1999, 14:233-238.
35. She Q.B., Nagao I., Hayakawa T., Tsuge H. A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem. Biophys. Res. Commun. 1994, 205:1748-1754.
36. Stern P.H., Hoffman R.M. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J. Natl. Cancer Inst. 1986, 76:629-639.
37. Stipanuk M.H. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu. Rev. Nutr. 2004, 24:539-577.
38. Stresemann C., Brueckner B., Musch T., Stopper H., Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 2006, 66:2794-2800.
39. Teixeira K.C., Soares F.S., Rocha L.G., Silveira P.C., Silva L.A., Valença S.S., Dal Pizzol F., Streck E.L., Pinho R.A. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm. Pharmacol. Ther. 2008, 21:309-316.
40. Wang K., Ramji S., Bhathena A., Lee C., Riddick D.S. Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines. Xenobiotica 1999, 29:155-170.
41. Yan C.C., Huxtable R.J. Fluorimetric determination of monobromobimane and o-phthalaldehyde adducts of gamma-glutamylcysteine and glutathione: application to assay of gamma-glutamylcysteinyl synthetase activity and glutathione concentration in liver. J. Chromatogr. B Biomed. Appl. 1995, 672:217-224.